Aurélie Petit-Monéger1, Muriel Rainfray2, Pierre Soubeyran3, Carine A Bellera4, Simone Mathoulin-Pélissier5. 1. Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Centre, 229 cours de l'Argonne, F-33000 Bordeaux, France; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Clinical Epidemiology and Clinical Investigation Centre CIC-1401, Clinical Epidemiology Module, F-33000 Bordeaux, France; Bordeaux University, 146 rue Léo Saignat, F-33000 Bordeaux, France. Electronic address: aurelie.petit-moneger@isped.u-bordeaux2.fr. 2. Bordeaux University, 146 rue Léo Saignat, F-33000 Bordeaux, France; Department of Clinical Gerontology, Bordeaux University Hospital, F-33604 Pessac, France. Electronic address: muriel.rainfray@chu-bordeaux.fr. 3. Bordeaux University, 146 rue Léo Saignat, F-33000 Bordeaux, France; Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Centre, 229 cours de l'Argonne, F-33000 Bordeaux, France. Electronic address: p.soubeyran@bordeaux.unicancer.fr. 4. Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Centre, 229 cours de l'Argonne, F-33000 Bordeaux, France; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Clinical Epidemiology and Clinical Investigation Centre CIC-1401, Clinical Epidemiology Module, F-33000 Bordeaux, France. Electronic address: c.bellera@bordeaux.unicancer.fr. 5. Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Centre, 229 cours de l'Argonne, F-33000 Bordeaux, France; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Clinical Epidemiology and Clinical Investigation Centre CIC-1401, Clinical Epidemiology Module, F-33000 Bordeaux, France; Bordeaux University, 146 rue Léo Saignat, F-33000 Bordeaux, France. Electronic address: s.mathoulin@bordeaux.unicancer.fr.
Abstract
OBJECTIVE: The G8 is a screening test to identify frail elderly patients with cancer. Objectives were to design and evaluate the performance of alternative tests taking into account other predictive domains for frailty. METHODS: We conducted a literature review to identify predictive factors of frailty. Using a Delphi consensus, we collected 24 European experts' opinions to validate the most relevant items to improve the G8. Alternative tests were created and performance assessed on a development population (ONCODAGE cohort). The highest performing test was compared to the G8, and validated through both an internal and an external population validation (Aquitaine Geriatric Oncology cohort). RESULTS: The study population consisted of 1435 patients (ONCODAGE cohort) and 364 patients (Aquitaine Geriatric Oncology cohort). Twenty-three experts validated two items with a strong consensus (>75%): modification of the threshold for the G8 polypharmacy item to six drugs per day and replacement of the G8 item on neuropsychological problems by four Instrumental Activities of Daily Living (IADL) items predictive of incident dementia, creating three modified G8 tests (addition of either item, or both). Only the G8 IADL-modified test had better performance than the G8 when tested on the ONCODAGE cohort: sensitivity=77%, specificity=67%. This test was validated on the internal (sensitivity=78%, specificity=71%) and external (sensitivity=88%, specificity=69%) validation populations. CONCLUSION: Adding the four IADL items improves the performance of the G8. We have developed and validated a G8-modified test that is more specific than the G8 to detect frail elderly, while still sensitive and feasible in less than 10 min.
OBJECTIVE: The G8 is a screening test to identify frail elderly patients with cancer. Objectives were to design and evaluate the performance of alternative tests taking into account other predictive domains for frailty. METHODS: We conducted a literature review to identify predictive factors of frailty. Using a Delphi consensus, we collected 24 European experts' opinions to validate the most relevant items to improve the G8. Alternative tests were created and performance assessed on a development population (ONCODAGE cohort). The highest performing test was compared to the G8, and validated through both an internal and an external population validation (Aquitaine Geriatric Oncology cohort). RESULTS: The study population consisted of 1435 patients (ONCODAGE cohort) and 364 patients (Aquitaine Geriatric Oncology cohort). Twenty-three experts validated two items with a strong consensus (>75%): modification of the threshold for the G8 polypharmacy item to six drugs per day and replacement of the G8 item on neuropsychological problems by four Instrumental Activities of Daily Living (IADL) items predictive of incident dementia, creating three modified G8 tests (addition of either item, or both). Only the G8 IADL-modified test had better performance than the G8 when tested on the ONCODAGE cohort: sensitivity=77%, specificity=67%. This test was validated on the internal (sensitivity=78%, specificity=71%) and external (sensitivity=88%, specificity=69%) validation populations. CONCLUSION: Adding the four IADL items improves the performance of the G8. We have developed and validated a G8-modified test that is more specific than the G8 to detect frail elderly, while still sensitive and feasible in less than 10 min.
Authors: Dominique Bron; Igor Aurer; Marc P E André; Christophe Bonnet; Dolores Caballero; Claire Falandry; Eva Kimby; Pierre Soubeyran; Emanuele Zucca; Andre Bosly; Bertrand Coiffier Journal: Haematologica Date: 2017-06 Impact factor: 9.941
Authors: Ronald Maggiore; Zachary S Zumsteg; Karlynn BrintzenhofeSzoc; Kelly M Trevino; Ajeet Gajra; Beatriz Korc-Grodzicki; Joel B Epstein; Stewart M Bond; Ira Parker; Julie A Kish; Barbara A Murphy; Noam A VanderWalde Journal: Int J Radiat Oncol Biol Phys Date: 2017-07-15 Impact factor: 7.038
Authors: Fabio Traunero; Francesco Claps; Tommaso Silvestri; Maria Carmen Mir; Luca Ongaro; Michele Rizzo; Andrea Piasentin; Giovanni Liguori; Francesca Vedovo; Antonio Celia; Carlo Trombetta; Nicola Pavan Journal: J Clin Med Date: 2022-06-30 Impact factor: 4.964
Authors: Bhavana Pothuri; Angeles Alvarez Secord; Deborah K Armstrong; John Chan; Amanda N Fader; Warner Huh; Joshua Kesterson; Joyce F Liu; Kathleen Moore; Shannon N Westin; R Wendel Naumann Journal: Gynecol Oncol Date: 2020-04-23 Impact factor: 5.482
Authors: Laura Biganzoli; Fatima Cardoso; Marc Beishon; David Cameron; Luigi Cataliotti; Charlotte E Coles; Roberto C Delgado Bolton; Maria Die Trill; Sema Erdem; Maria Fjell; Romain Geiss; Mathijs Goossens; Christiane Kuhl; Lorenza Marotti; Peter Naredi; Simon Oberst; Jean Palussière; Antonio Ponti; Marco Rosselli Del Turco; Isabel T Rubio; Anna Sapino; Elzbieta Senkus-Konefka; Marko Skelin; Berta Sousa; Tiina Saarto; Alberto Costa; Philip Poortmans Journal: Breast Date: 2020-02-26 Impact factor: 4.380
Authors: M E C van Winden; S Garcovich; K Peris; G Colloca; E M G J de Jong; M E Hamaker; P C M van de Kerkhof; S F K Lubeek Journal: J Eur Acad Dermatol Venereol Date: 2020-07-01 Impact factor: 9.228